Literature DB >> 15233725

Targeting plasmid-encoded proteins to the antigen presentation pathways.

Jens A Leifert1, Maria P Rodriguez-Carreno, Fernando Rodriguez, J Lindsay Whitton.   

Abstract

The antigen presentation pathways constitute a fulcrum on which adaptive immunity is balanced, and their manipulation should allow us to induce designer immune responses. The ease and rapidity with which DNA vaccines can be constructed and altered make them ideal candidates with which to test the various targeting strategies that have been conceived to date. These approaches and the mechanisms that may (or may not) underlie their success are reviewed in this article.

Mesh:

Substances:

Year:  2004        PMID: 15233725     DOI: 10.1111/j.0105-2896.2004.0135.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  15 in total

1.  Biomaterials at the interface of nano- and micro-scale vector-cellular interactions in genetic vaccine design.

Authors:  Charles H Jones; Anders P Hakansson; Blaine A Pfeifer
Journal:  J Mater Chem B       Date:  2014-09-12       Impact factor: 6.331

Review 2.  Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease.

Authors:  Robert S Fujinami; Matthias G von Herrath; Urs Christen; J Lindsay Whitton
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

3.  Systemic immunization with CCL27/CTACK modulates immune responses at mucosal sites in mice and macaques.

Authors:  Kimberly A Kraynyak; Michele A Kutzler; Neil J Cisper; Amir S Khan; Ruxandra Draghia-Akli; Niranjan Y Sardesal; Mark G Lewis; Jian Yan; David B Weiner
Journal:  Vaccine       Date:  2010-02-23       Impact factor: 3.641

4.  Targeting HPV-16 antigens to the endoplasmic reticulum induces an endoplasmic reticulum stress response.

Authors:  David H Martínez-Puente; José J Pérez-Trujillo; Yolanda Gutiérrez-Puente; Humberto Rodríguez-Rocha; Aracely García-García; Odila Saucedo-Cárdenas; Roberto Montes-de-Oca-Luna; María J Loera-Arias
Journal:  Cell Stress Chaperones       Date:  2019-01-02       Impact factor: 3.667

Review 5.  Plasmid DNA vaccine vector design: impact on efficacy, safety and upstream production.

Authors:  James A Williams; Aaron E Carnes; Clague P Hodgson
Journal:  Biotechnol Adv       Date:  2009-02-20       Impact factor: 14.227

Review 6.  DC-based cancer vaccines.

Authors:  Eli Gilboa
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

Review 7.  DNA vaccines: developing new strategies against cancer.

Authors:  Daniela Fioretti; Sandra Iurescia; Vito Michele Fazio; Monica Rinaldi
Journal:  J Biomed Biotechnol       Date:  2010-03-28

Review 8.  Application of advances in endocytosis and membrane trafficking to drug delivery.

Authors:  Yaping Ju; Hao Guo; Maria Edman; Sarah F Hamm-Alvarez
Journal:  Adv Drug Deliv Rev       Date:  2020-08-03       Impact factor: 15.470

9.  Targeting myelin proteolipid protein to the MHC class I pathway by ubiquitination modulates the course of experimental autoimmune encephalomyelitis.

Authors:  Diethilde J Theil; Jane E Libbey; Fernando Rodriguez; J Lindsay Whitton; Ikuo Tsunoda; Tobias J Derfuss; Robert S Fujinami
Journal:  J Neuroimmunol       Date:  2008-11-15       Impact factor: 3.478

10.  Plasmid-encoded interleukin-15 receptor alpha enhances specific immune responses induced by a DNA vaccine in vivo.

Authors:  Kimberly A Kraynyak; Michele A Kutzler; Neil J Cisper; Dominick J Laddy; Matthew P Morrow; Thomas A Waldmann; David B Weiner
Journal:  Hum Gene Ther       Date:  2009-10       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.